Arcadia Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.9K | Hold |
856
| – | – | 0.01% | 160 |
|
|
2025
Q1 | $86.4K | Hold |
856
| – | – | 0.02% | 170 |
|
|
2024
Q4 | $76.5K | Buy |
856
+230
| +37% | +$20.5K | 0.01% | 186 |
|
|
2024
Q3 | $52.5K | Hold |
626
| – | – | 0.01% | 182 |
|
|
2024
Q2 | $48.2K | Hold |
626
| – | – | 0.01% | 206 |
|
|
2024
Q1 | $42.9K | Hold |
626
| – | – | 0.01% | 212 |
|
|
2023
Q4 | $36.2K | Hold |
626
| – | – | 0.01% | 226 |
|
|
2023
Q3 | $33.1K | Hold |
626
| – | – | 0.01% | 237 |
|
|
2023
Q2 | $33.9K | Buy |
626
+200
| +47% | +$10.8K | 0.01% | 241 |
|
|
2023
Q1 | $21.3K | Hold |
426
| – | – | ﹤0.01% | 286 |
|
|
2022
Q4 | $19.7K | Buy |
426
+296
| +228% | +$13.7K | ﹤0.01% | 276 |
|
|
2022
Q3 | $5K | Hold |
130
| – | – | ﹤0.01% | 263 |
|
|
2022
Q2 | $5K | Hold |
130
| – | – | ﹤0.01% | 272 |
|
|
2022
Q1 | $6K | Hold |
130
| – | – | ﹤0.01% | 267 |
|
|
2021
Q4 | $6K | Hold |
130
| – | – | ﹤0.01% | 270 |
|
|
2021
Q3 | $6K | Hold |
130
| – | – | ﹤0.01% | 259 |
|
|
2021
Q2 | $6K | Buy |
+130
| New | +$6K | ﹤0.01% | 273 |
|